1 2 3 4 5

A Phase 1 Trial of Cabazitaxel Combined With 188Re–Hydroxyethylidene Diphosphonate in Patients With Metastatic Castration-Resistant Prostate Cancer Who Progressed on or After a...

van Dodewaard-de Jong, Joyce M.; Bouman-Wammes, Esther W.; Bloemendal, Haiko J.; More

Clinical Nuclear Medicine . 42(6):415-420, June 2017.

Peptide Receptor Radionuclide Therapy With 177Lu-Octreotate in Patients With Somatostatin Receptor Expressing Neuroendocrine Tumors: Six Years' Assessment

Hamiditabar, Mohammadali; Ali, Muzammil; Roys, Joseph; More

Clinical Nuclear Medicine . 42(6):436-443, June 2017.

Multiple Time-Point 68Ga-PSMA I&T PET/CT for Characterization of Primary Prostate Cancer: Value of Early Dynamic and Delayed Imaging

Schmuck, Sebastian; Mamach, Martin; Wilke, Florian; More

Clinical Nuclear Medicine . 42(6):e286-e293, June 2017.

Initial Experience Using 99mTc-MIBI SPECT/CT for the Differentiation of Oncocytoma From Renal Cell Carcinoma

Rowe, Steven P.; Gorin, Michael A.; Gordetsky, Jennifer; More

Clinical Nuclear Medicine . 40(4):309-313, April 2015.

Accidental Discovery of Lung Metastases From Differentiated Thyroid Cancer by 99mTc Sodium Pertechnetate Scan in a Patient With Secondary Hyperparathyroidism

Campennì, Alfredo; Ruggeri, Rosaria M.; Santoro, Domenico; More

Clinical Nuclear Medicine . 37(9):895-896, September 2012.

1 2 3 4 5